<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Publicaciones &#8211; Grupo TTD</title>
	<atom:link href="https://grupottd.org/publicaciones/feed/" rel="self" type="application/rss+xml" />
	<link>https://grupottd.org</link>
	<description>Grupo de Tratamiento de los Tumores Digestivos</description>
	<lastBuildDate>Mon, 28 Sep 2026 15:13:31 +0000</lastBuildDate>
	<language>es</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.1.4</generator>

<image>
	<url>https://grupottd.org/wp-content/uploads/2026/03/cropped-Logo-TTD-favicon-32x32.png</url>
	<title>Publicaciones &#8211; Grupo TTD</title>
	<link>https://grupottd.org</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Current patterns of next-generation sequencing testing in biliary tract cancer patients in Spain</title>
		<link>https://grupottd.org/publicaciones/current-patterns-of-next-generation-sequencing-testing-in-biliary-tract-cancer-patients-in-spain/</link>
		
		<dc:creator><![CDATA[Antonio Martín]]></dc:creator>
		<pubDate>Mon, 28 Sep 2026 15:13:30 +0000</pubDate>
				<guid isPermaLink="false">https://grupottd.org/?post_type=publicaciones&#038;p=13738</guid>

					<description><![CDATA[]]></description>
										<content:encoded><![CDATA[]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Epidemiological characterization of biliary tract cancer in a real-world cohort of patients from the Spanish TTD-RETUD gastrointestinal registry</title>
		<link>https://grupottd.org/publicaciones/epidemiological-characterization-of-biliary-tract-cancer-in-a-real-world-cohort-of-patients-from-the-spanish-ttd-retud-gastrointestinal-registry/</link>
		
		<dc:creator><![CDATA[Antonio Martín]]></dc:creator>
		<pubDate>Mon, 28 Sep 2026 15:11:00 +0000</pubDate>
				<guid isPermaLink="false">https://grupottd.org/?post_type=publicaciones&#038;p=13737</guid>

					<description><![CDATA[]]></description>
										<content:encoded><![CDATA[]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Current patterns of next‑generation sequencing implementation in hepatocellular carcinoma in Spain</title>
		<link>https://grupottd.org/publicaciones/current-patterns-of-next%e2%80%91generation-sequencing-implementation-in-hepatocellular-carcinoma-in-spain/</link>
		
		<dc:creator><![CDATA[Juan Jose Barea]]></dc:creator>
		<pubDate>Wed, 23 Sep 2026 13:20:36 +0000</pubDate>
				<guid isPermaLink="false">https://grupottd.org/?post_type=publicaciones&#038;p=13730</guid>

					<description><![CDATA[]]></description>
										<content:encoded><![CDATA[]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Surgical management of stage IV gastricadenocarcinoma: A systematic review and expert recommendations from the Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) and the Spanish Association of Surgeons (AEC)</title>
		<link>https://grupottd.org/publicaciones/surgical-management-of-stage-iv-gastricadenocarcinoma-a-systematic-review-and-expertrecommendations-from-the-spanish-cooperativegroup-for-the-treatment-of-digestive-tumours-ttdand-the-spanish-assoc/</link>
		
		<dc:creator><![CDATA[Juan Jose Barea]]></dc:creator>
		<pubDate>Fri, 09 Jan 2026 11:47:43 +0000</pubDate>
				<guid isPermaLink="false">https://grupottd.org/?post_type=publicaciones&#038;p=10701</guid>

					<description><![CDATA[]]></description>
										<content:encoded><![CDATA[]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Real‑world management and outcomes of patientswith hepatocellular carcinoma treated with systemic therapy in Spain: a patient cohort from the RETUD gastrointestinal registry</title>
		<link>https://grupottd.org/publicaciones/real%e2%80%91world-management-and-outcomes-of-patientswith-hepatocellular-carcinoma-treated-with-systemic-therapy-in-spain-a-patient-cohort-from-the-retud-gastrointestinal-registry/</link>
		
		<dc:creator><![CDATA[Juan Jose Barea]]></dc:creator>
		<pubDate>Fri, 09 Jan 2026 11:44:18 +0000</pubDate>
				<guid isPermaLink="false">https://grupottd.org/?post_type=publicaciones&#038;p=10700</guid>

					<description><![CDATA[]]></description>
										<content:encoded><![CDATA[]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Clinical validation of Liquid Biopsy-RECIST (LB-RECIST) in metastatic colorectal cancer (mCRC) patients: findings from the PLATFORM-B study</title>
		<link>https://grupottd.org/publicaciones/clinical-validation-of-liquid-biopsy-recist-lb-recist-in-metastatic-colorectal-cancer-mcrc-patients-findings-from-the-platform-b-study/</link>
		
		<dc:creator><![CDATA[Administrador CMLD Pruebas]]></dc:creator>
		<pubDate>Mon, 29 Sep 2025 22:05:24 +0000</pubDate>
				<guid isPermaLink="false">https://grupottd.org/?post_type=publicaciones&#038;p=7699</guid>

					<description><![CDATA[]]></description>
										<content:encoded><![CDATA[]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Definition of lines of treatment in metastatic colorectal cancer: A Delphi consensus</title>
		<link>https://grupottd.org/publicaciones/definition-of-lines-of-treatment-in-metastatic-colorectal-cancer-a-delphi-consensus/</link>
		
		<dc:creator><![CDATA[Administrador CMLD Pruebas]]></dc:creator>
		<pubDate>Mon, 29 Sep 2025 22:04:43 +0000</pubDate>
				<guid isPermaLink="false">https://grupottd.org/?post_type=publicaciones&#038;p=7698</guid>

					<description><![CDATA[]]></description>
										<content:encoded><![CDATA[]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Circulating hsa-miR-29c-3p and VEGF-A levels predict the response to FOLFIRI plus aflibercept in elderly metastatic colorectal cancer patients </title>
		<link>https://grupottd.org/publicaciones/circulating-hsa-mir-29c-3p-and-vegf-a-levels-predict-the-response-to-folfiri-plus-aflibercept-in-elderly-metastatic-colorectal-cancer-patients/</link>
		
		<dc:creator><![CDATA[Administrador CMLD Pruebas]]></dc:creator>
		<pubDate>Mon, 29 Sep 2025 11:38:17 +0000</pubDate>
				<guid isPermaLink="false">https://grupottd.org/?post_type=publicaciones&#038;p=7625</guid>

					<description><![CDATA[]]></description>
										<content:encoded><![CDATA[]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>TTD expert consensus on emesis in gastric cancer: evidence-based strategies for prevention and treatment</title>
		<link>https://grupottd.org/publicaciones/prueba-ttd-expert-consensus-on-emesis-in-gastric-cancer-evidence-based-strategies-for-prevention-and-treatment/</link>
		
		<dc:creator><![CDATA[Administrador CMLD Pruebas]]></dc:creator>
		<pubDate>Mon, 29 Sep 2025 11:34:52 +0000</pubDate>
				<guid isPermaLink="false">https://grupottd.org/?post_type=publicaciones&#038;p=7624</guid>

					<description><![CDATA[]]></description>
										<content:encoded><![CDATA[]]></content:encoded>
					
		
		
			</item>
	</channel>
</rss>
